Brian Russell Wong

President, Chief Executive Officer & Director at Rapt Therapeutics, Inc.

Brian Russell Wong

Brian Russell Wong

President, Chief Executive Officer & Director at Rapt Therapeutics, Inc.

Overview
Career Highlights

Rapt Therapeutics, Inc.

RelSci Relationships

652

Number of Boards

1

Birthday

1972

Age

49

Relationships
RelSci Relationships are individuals Brian Russell Wong likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chief Executive Officer at Rapt Therapeutics, Inc.

Relationship likelihood: Strong

Executive Chairman & Secretary at NGM Biopharmaceuticals, Inc.

Relationship likelihood: Strong

Former Head-Immuno Oncology & Oncology Product at Bristol-Myers Squibb Company

Relationship likelihood: Strong

Chief Financial Officer & Secretary at Rapt Therapeutics, Inc.

Relationship likelihood: Strong

Chief Scientific Officer at Rapt Therapeutics, Inc.

Relationship likelihood: Strong

Founder at The Column Group LLC

Relationship likelihood: Strong

Scientific Co-Founder at Vedanta Biosciences, Inc.

Relationship likelihood: Strong

Chief of Preclinical Development at NeuBase Therapeutics, Inc.

Relationship likelihood: Strong

Former Senior Vice President & Head-Oncology Development at Bristol-Myers Squibb Company

Relationship likelihood: Strong

Founder at Gray Strategic Advisors LLC

Relationship likelihood: Strong

Paths to Brian Russell Wong
Potential Connections via
Relationship Science
You
Brian Russell Wong
President, Chief Executive Officer & Director at Rapt Therapeutics, Inc.
Education
Ph.D. in Immunology

The Rockefeller University (the University) is a world renowned center for research (see schedule O) and graduate education in the biomedical sciences, chemistry, bioinformatics, and physics. The University's 82 laboratories conduct both clinical and basic research and study a diverse range of biological and biomedical problems with the mission of improving the understanding of life for the benefit of humanity. Laboratories are loosely clustered in nine research areas covering a wide spectrum of disciplines in the life sciences, including neuroscience, immunology, genetics, structural biology and bioinformatics. The University does not charge tuition. Its revenues are derived primarily from investment income, government grants and contracts, and private gifts and grants.

MD

Founded in 1898, and affiliated with what is now NewYork-Presbyterian Hospital since 1927, Weill Cornell Medical College is among the top-ranked clinical and medical research centers in the country. In addition to offering degrees in medicine, Weill Cornell also has PhD programs in biomedical research and education at the Weill Cornell Graduate School of Medical Sciences, and with neighboring Sloan-Kettering Institute and The Rockefeller University, has established a joint MD-PhD program for students to intensify their pursuit of Weill Cornell's triple mission of education, research, and patient care. Weill Cornell Medical College is divided into 24 basic science and patient care departments that focus on the sciences underlying clinical medicine and/or encompass the study, treatment, and prevention of human diseases. In addition to its affiliation with NewYork-Presbyterian Hospital, Weill Cornell Medical College and the Weill Cornell Graduate School of Medical Sciences maintain major affiliations with Memorial Sloan-Kettering Cancer Center, The Rockefeller University, the Hospital for Special Surgery, as well as with the metropolitan-area institutions that constitute NewYork-Presbyterian Healthcare Network. Weill Cornell Medical College and the Weill Cornell Graduate School of Medical Sciences are accredited by the Liaison Committee for Medical Education of the American Medical Association and the Association of American Medical Colleges.

BA Chemistry & Biochemistry

Oberlin College is a private liberal arts college in Oberlin, Ohio, noteworthy for having been the first American institution of higher learning to regularly admit female and black students in addition to white males. Oberlin is a member of the Great Lakes Colleges Association and the Five Colleges of Ohio consortium.

Career History
Senior Vice President-Research & Head-Immuno Oncology
2009 - 2015

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on discovering and developing novel protein therapeutics. Its product candidates includes, Cabiralizumab(FPA008), Bemarituzumab(FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, CA.

Research Director
Prior
Director-Research
2005 - 2009

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Boards & Committees
President, Chief Executive Officer & Director
2015 - Current

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.

Transactions
Details Hidden

Rapt Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Rapt Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Rapt Therapeutics, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Brian Russell Wong. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Brian Russell Wong's profile does not indicate a business or promotional relationship of any kind between RelSci and Brian Russell Wong.